Pfizer buys exclusive rights to NicOx eye treatment technology

03/3/2006 | MSNBC

France's largest biotech company, NicOx, signed a multimillion-dollar deal with Pfizer giving the American company exclusive rights to its technology for developing treatments for eye diseases. The technology is based on nitric oxide-donating techniques for use in opthalmology.

View Full Article in:

MSNBC

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
MGR POST MARKET STUDIES - 14000001LK
Abbott
Santa Ana, CA
Regulatory Analyst
Delta Dental
Alpharetta, GA
Program Coordinator/Lecturer for the Regulatory Science program
Johns Hopkins University
Washington, DC
Eastern Zone Sales Director
Regenesis Biomedical
Multiple Locations, SL_Multiple Locations
Senior Financial Analyst - Growing Manager Care Health Org
Fallon Community Health Plan
Worcester, MA